As seen on — Media coverage
Neurotherapeutix has been featured in national media for its pioneering work in functional brain imaging and personalized brain-based care.
These appearances provide an opportunity to educate patients, families, and the broader public about advances in neuroscience and how TMS therapy works through individualized treatment planning.
ABC News / Good Morning America — March 12, 2024
A look at our correspondent’s brain on sugar
ABC News Chief Medical Correspondent Dr. Jennifer Ashton joined correspondent Phil Lipof and neuroscientist Dr. Nicole Avena to explore how sugar affects the brain. During the segment, advanced functional brain imaging was used to examine changes in brain activity before and after sugar consumption, providing viewers with a real-world example of how neuroscience can help visualize brain function.
This national television appearance highlighted the growing role of advanced brain imaging in understanding human behavior and brain health while introducing viewers to the potential of personalized functional imaging technologies.
BRAIN MAPPING
Patented technologies
Innovation is central to Neurotherapeutix’s approach to personalized care.
Developed by Dr. Marta Moreno, Dr. Alayar Kangarlu, and the Neurotherapeutix team, the proprietary, patented computational technology uses computational brain mapping to inform individualized fMRI-guided TMS therapy. Using patented computational methods, Neurotherapeutix analyzes each patient’s resting-state fMRI data to evaluate functional connectivity and intrinsic brain activity across key neural networks.
These individualized patterns are compared with age-matched reference data from healthy brains to identify regions and networks that may show atypical activity or connectivity. This information helps guide a personalized treatment plan, including the selection of fMRI-informed TMS targets and treatment parameters tailored to each patient’s unique brain-connectivity profile.
Rather than relying solely on standardized anatomical landmarks, this patented technology integrates advanced functional imaging into individualized treatment planning.
These patented methods represent years of research and scientific development focused on improving the precision of brain-based treatments.
- Landa A, Wang Z, Russell JA, Posner J, Duan Y, Kangarlu A, Huo Y, Fallon BA, Peterson BS.: Distinct neural circuits subserve interpersonal and non-interpersonal emotions.. Soc Neurosci. 2013;8: 474-88
- Colibazzi T, Posner J, Wang Z, Gorman D, Gerber A, Yu S, Zhu H, Kangarlu A, Duan Y, Russell JA, Peterson BS.: Neural systems subserving valence and arousal during the experience of induced emotions.. Emotion 2010;10: 377-89
- Liu F, Garland M, Duan Y, Stark RI, Xu D, Bansal R, Dong Z, Peterson BS, Kangarlu A.: Techniques for in utero, longitudinal MRI of fetal brain development in baboons at 3T.. J Magn Reson Imaging 2009;29: 13-22
- Kangarlu A.: High-field magnetic resonance imaging. Neuroimaging Clin N America 2009;19: 113-28
- Posner J, Russell JA, Gerber A, Gorman D, Colibazzi T, Yu S, Wang Z, Kangarlu A, Zhu H, Peterson BS.: The neurophysiological bases of emotion: An fMRI study of the affective circumplex using emotion-denoting words. Hum Brain Mapp. 2009;30: 883-95
Our research
The Neurotherapeutix team has authored and contributed to numerous peer-reviewed publications exploring brain function, functional connectivity, magnetic resonance imaging, depression, bipolar disorder, schizophrenia, neuromodulation, and advanced imaging technologies.
Many of these publications have helped advance the understanding of how functional brain networks influence neurological and psychiatric conditions and continue to inform the evolution of computational brain mapping and personalized treatment planning.
Our published work reflects a longstanding commitment to scientific discovery, evidence-informed medicine, and continuous innovation in neuroscience.
Failure of deactivation in bipolar disorder during performance of an fMRI adapted version of the Stroop task
N Verdolini, M Moreno-Ortega, P Salgado-Pineda, G Monté, …
Journal of Affective Disorders 329, 307-314
1 2023
Activation and deactivation patterns in schizophrenia during performance of an fMRI adapted version of the stroop task
P Salgado-Pineda, R Rodriguez-Jimenez, M Moreno-Ortega, …
Journal of Psychiatric Research 144, 1-7
42021
Frequency drift in MR spectroscopy at 3T
SCN Hui, M Mikkelsen, HJ Zöllner, V Ahluwalia, S Alcauter, L Baltusis, …
NeuroImage 241, 118430
282021
Parcel-guided rTMS for depression
M Moreno-Ortega, A Kangarlu, S Lee, T Perera, J Kangarlu, T Palomo, …
Translational psychiatry 10 (1), 283
322020
Comparison of multivendor single-voxel MR spectroscopy data acquired in healthy brain at 26 sites
M Považan, M Mikkelsen, A Berrington, PK Bhattacharyya, MK Brix, …
Radiology 295 (1), 171-180
412020
Big GABA II: Water-referenced edited MR spectroscopy at 25 research sites
M Mikkelsen, DL Rimbault, PB Barker, PK Bhattacharyya, MK Brix, …
Neuroimage 191, 537-548
802019
Resting state functional connectivity predictors of treatment response to electroconvulsive therapy in depression
M Moreno-Ortega, J Prudic, S Rowny, GH Patel, A Kangarlu, S Lee, …
Scientific reports 9 (1), 5071
542019
Integrative Analysis of GABA-Edited MRS Data Acquired at 24 Research Sites
M Mikkelsen, PB Barker, PK Bhattacharayya, MK Brix, PF Buur, KM Cecil, …
International Society for Magnetic Resonance in Medicine, Date: 2017/04/22 …
2017
Neural systems subserving valence and arousal during the experience of induced emotions.
T Colibazzi, J Posner, Z Wang, D Gorman, A Gerber, S Yu, H Zhu, …
Emotion 10 (3), 377
3402010
The neurophysiological bases of emotion: An fMRI study of the affective circumplex using emotion‐denoting words
J Posner, JA Russell, A Gerber, D Gorman, T Colibazzi, S Yu, Z Wang, …
Human brain mapping 30 (3), 883-895
2742009
An affective circumplex model of neural systems subserving valence, arousal, and cognitive overlay during the appraisal of emotional faces
AJ Gerber, J Posner, D Gorman, T Colibazzi, S Yu, Z Wang, A Kangarlu, …
Neuropsychologia 46 (8), 2129-2139
2412008
Cognitive, cardiac, and physiological safety studies in ultra high field magnetic resonance imaging
A Kangarlu, RE Burgess, H Zhu, T Nakayama, RL Hamlin, AM Abduljalil, …
Magnetic resonance imaging 17 (10), 1407-1416
2351999
Effect of static magnetic field exposure of up to 8 Tesla on sequential human vital sign measurements
DW Chakeres, A Kangarlu, H Boudoulas, DC Young
Journal of Magnetic Resonance Imaging: An Official Journal of the …
1972003
Human magnetic resonance imaging at 8 T
PML Robitaille, AM Abduljalil, A Kangarlu, X Zhang, Y Yu, R Burgess, …
NMR in Biomedicine: An International Journal Devoted to the Development and …
1881998
Big GABA: Edited MR spectroscopy at 24 research sites
M Mikkelsen, PB Barker, PK Bhattacharyya, MK Brix, PF Buur, KM Cecil, …
Neuroimage 159, 32-45
1822017
Biological effects and health implications in magnetic resonance imaging
A Kangarlu, PML Robitaille
Concepts in Magnetic Resonance: An Educational Journal 12 (5), 321-359
1602000
Source
Our Research
OUR BLOGS
In The News
The blog aims to provide readers with valuable information, insights, and resources to better understand and utilize neurotherapy for enhancing brain health and optimizing mental well-being.
Why early intervention in mental health is becoming the standard
Mental health care is changing. Instead of waiting for symptoms to worsen before seeking...
Who Does Our TMS Treatment Help?
We believe it’s important for the community to understand both how we help and...
Frequently asked questions
What makes Neurotherapeutix’s technology patented and unique?
Neurotherapeutix is the only clinical practice in the United States offering proprietary, patented computational brain mapping to inform personalized fMRI-guided TMS therapy.
By combining advanced functional imaging with individualized treatment planning, this technology helps clinicians evaluate each patient’s unique brain-connectivity profile before treatment begins and identify targets that may best align with their clinical needs.
Has Neurotherapeutix been featured in national media?
Yes. Neurotherapeutix has been featured by national media outlets, including ABC News and Good Morning America, where members of the clinical team have shared insights into functional brain imaging, neuroscience, and personalized approaches to brain health.
Where can I read the published research behind fMRI-guided TMS therapy?
The Neurotherapeutix team has contributed to numerous peer-reviewed publications on functional MRI, brain connectivity, neuropsychiatry, magnetic resonance imaging, and neuromodulation. A selection of these publications is available on this page, along with links to additional research.
Advancing personalized brain-based care through research and innovation
Scientific discovery and patient care go hand in hand at Neurotherapeutix. Through ongoing research, patented technologies, national media education, and clinical innovation, our team continues to advance the field of personalized brain-based treatment.
If you’d like to learn more about our approach, explore our patient testimonials to hear about others’ experiences, or request an appointment to discuss whether personalized care may be appropriate for your individual needs.
